Editorji is a popular short video news and information platform based in India. It was founded in 2018 by Vikram Chandra, one of India’s leading journalists, and has risen to prominence in the digital news space in a relatively short span of time. The platform is primarily designed for mobile devices, with applications available for Android and iOS.

ABOUT US:

about us editorji

Latest Video News: Editorji provides the latest news video headlines, latest videos clip from India and the World. Get all breaking news videos on Entertainment, Business, Coronavirus, Elections, Politics and more.

Latest Video News, Breaking News, Bollywood, Political, Sports, Business News | Editorji

+91 11 4035 6666 / info@editorji.com
3rd floor, Plot B, Khasara no 360, Sultanpur, New Delhi, Delhi 110030
<a title="mail to us" href="mailto:info@editorji.com">Send Feedback</a>
<a title="Contact Us" href="mailto:info@editorji.com">Contact Us</a>

REACH US

Contact for any questions, suggestions, comments, feedback or advertisement on Editorji.com, we are always looking forward to hearing from you.

Contact Us for Feedback, Suggestions and Advertising 

Editorji content is better experienced in our app.

Air pollution causes millions of deaths worldwide each year, including more than 250,000 from a type of lung cancer

Air pollution wakes up dormant cells that cause lung cancer: Study 

Air pollution causes millions of deaths worldwide each year, including more than 250,000 from a type of lung cancer

A new study has found that air pollution can cause lung cancer in people who have never smoked by waking up dormant cancer cells.
Published in the journal Nature, the team noticed a significant association between PM2.5 levels and the incidence of lung cancer cases.
The findings suggested that air pollution wakes cancer-causing mutations in the lungs, encouraging them to grow and potentially form tumours. &nbsp; &nbsp; &nbsp;Also watch: <a href="https://www.editorji.com/story/women-with-low-fibre-intake-more-prone-to-breast-cancer-1586194992502">Women with low fibre intake more prone to breast cancer&nbsp;</a> &nbsp;

Amid reports emerging of first ever human trial of the cancer-killing drug being conducted, there are speculations about when will the drug be available in the market.
To those waiting patiently all these years, you will have to wait for some more time before the drug is available for treatment purposes.
The patients will not be able to get treated by the under-trial drug for at least another two years.
This is because the drug has just begun its human trial phase.
The trials are first aimed at determining whether the drug is safe for use in humans.
It will be only after that it will be tested for actively killing cancer cells.
The entire process is expected to take at least two years, and will be spread over many test sites.
Moreover, the drug will be administered to over 100 cancer patients who have received at least two other standard treatment procedures.
In a historic first, the human trial process for the cancer-killing drug which will be known as Vaxinia has just begun.

When will cancer-killing drug be available in market? Here's a tentative timeline

Wondering how soon will the cancer-killing drug be available in market? Here's when

The trials are first aimed at determining whether the drug is safe for use in humans.

The first-ever human trial of a drug which might kill cancer has sparked speculation about when the&nbsp;drug will be available in the market.
However, the wait for as easier cancer cure is set to be longer. It would take at least two more years before patients get access to the under-trial drug.
This is because the drug has just begun its human trial phase. The trials are aimed at determining whether the drug is safe for use in humans. If declared safe, the drug will be tested for actively killing cancer cells.
Also watch:&nbsp;<a href="https://www.editorji.com/world-news/first-human-trial-of-cancer-killing-drug-conducted-all-you-need-to-know-1653466391508" target="_blank">First human trial of cancer-killing drug conducted: all you need to know</a>
The entire process is expected to take at least two years, and will be spread over many test sites.
Moreover, the drug will be administered to over 100 cancer patients who have received at least two other standard treatment procedures.

In what could be a major breakthrough in curing cancer in humans, an experimental cancer-killing drug has been administered to the first human test subject ever.The of the trial is to find if the drug which has been tentatively named CF33-hNIS is safe for use in humans, and effective in killing off cancerous tumours. 
The drug is a genetically engineered virus that targets and kills cancer-causing cells and tumours. The name of the drug candidate is Vaxinia. 
CF33-hNIS is an "oncolytic virus" which was genetically modified to target, infect, and kill cancer cells while leaving healthy cells untouched. 
CF33-hNIS is classified as a "chimeric vaccinia poxvirus" and it was developed by Professor Yuman Fong, Chairman of the Sangiacomo Family in Surgical Oncology at the City of Hope hospital in the United States of America. 
Oncolytic viruses, by design, target and selectively kill tumour cells, while simultaneously stimulating the immune system to act against cancerous tissue. 

First human trial of cancer-killing drug conducted: all you need to know

The drug&nbsp;is a genetically engineered virus that targets and kills cancer-causing cells and tumours.

In what could be a major breakthrough in curing cancer in humans, an experimental cancer-killing drug has been administered to the first human test subject ever. The of the trial is to find if the&nbsp;drug which has been tentatively named CF33-hNIS&nbsp;is safe for use in humans, and effective in killing off cancerous tumours.&nbsp;
The drug&nbsp;is a genetically engineered virus that targets and kills cancer-causing cells and tumours. The name of the drug candidate is Vaxinia.&nbsp;
CF33-hNIS is an "oncolytic virus" which was genetically modified to target, infect, and kill cancer cells while leaving healthy cells untouched.&nbsp;
CF33-hNIS is classified as a "chimeric vaccinia poxvirus" and it was developed by Professor Yuman Fong, Chairman of the Sangiacomo Family in Surgical Oncology at the City of Hope hospital in the United States of America.&nbsp;
Also watch:&nbsp;<a href="https://www.editorji.com/world-news/did-monkeypox-spread-by-sex-at-2-raves-in-europe-who-expert-answers-1653313537234" target="_blank">Did Monkeypox spread by sex at 2 raves in Europe? WHO expert answers</a>
Oncolytic viruses, by design, target and selectively kill tumour cells, while simultaneously stimulating the immune system to act against cancerous tissue.&nbsp;

Industrialist Ratan Tata accompanied Prime Minister Narendra Modi for the inauguration of 7 cancer care centres in Assam. At the event on April 28, the chairman of Tata Trusts revealed his mission in the last years of his life. Ratan Tata also addressed the gathering in Hindi, despite not being fluent in the language.
The cancer care centres are being set up by Assam Cancer Care Foundation (ACCF), a joint venture of the state government and Tata Trusts.
Tata said, "I can't make a speech in Hindi, so I shall try to communicate with all of you in English. The message will be the same. It will be from my heart. Today is a very important day in the history of the state of Assam. It is a day that raises Assam to a higher level in terms of healthcare and treatment of cancer that has not been experienced by the other states in the country."
Then Tata spoke in Hindi, "I shall not bore you with more statements. I shall just say that today is an important day for Assam. Today, Assam can tell the world that a small state has world-class cancer treatment centres. I thank the Prime Minister, Chief Minister, and PM Modi's government. I dedicate my last years to help make Assam a state that recognises, and is recognised by all."

Ratan Tata reveals mission in 'last years' of life, at Assam event with PM Modi on cancer care centre inauguration

THUMBNAIL IMAGE RATAN TATA SPEAKING (use full image, not cut out)
 THUMBNAIL TEXT 'DEDICATE MY LAST YEARS TO...'
&nbsp;
 ((SHORT OPENING BYTE WITH TRANSLATION - ONLY KEEP HALF SENTENCE AS MENTIONED, NOT FULL))
 RATAN TATA, CHAIRMAN, TATA TRUSTS ANI REC - 28 APR 2022 -&nbsp;Encoder 1 14-53-51
(0:15 - 0:23) TRANSLATION -&nbsp;I dedicate my last years to help make Assam...
&nbsp;
 ((RATAN TATA, MODI VISUALS AT EVENT))
 Industrialist Ratan Tata accompanied Prime Minister Narendra Modi for the inauguration of 7 cancer care centres in Assam. At the event on April 28, the chairman of Tata Trusts revealed his mission in the last years of his life. Ratan Tata also addressed the gathering in Hindi, despite not being fluent in the language. The cancer care centres are being set up by&nbsp;Assam Cancer Care Foundation (ACCF), a joint venture of the state government and Tata Trusts. &nbsp;
&nbsp;
 BYTE RATAN TATA, CHAIRMAN, TATA TRUSTS
 ANI REC - 28 APR 2022 - Encoder 1 14-43-51
(4:44 - 5:00)
 ANI REC - 28 APR 2022 -&nbsp;Encoder 1 14-48-51
(0:00 - 0:48,&nbsp;2:59 - 4:10
 ANI REC - 28 APR 2022 -&nbsp;Encoder 1 14-53-51
(0:15 - 0:34)
 TRANSLATION - I can't make a speech in Hindi, so I shall try to communicate with all of you in English. The message will be the same. It will be from my heart. Today is a very important day in the history of the state of Assam. It is a day that raises Assam to a higher level in terms of healthcare and treatment of cancer that has not been experienced by the other states in the country.&nbsp;I shall not bore you with more statements. I shall just say that today is an important day for Assam. Today, Assam can tell the world that a small state has world-class cancer treatment centres. I thank the Prime Minister, Chief Minister, and PM Modi's government. I dedicate my last years to help make Assam a state that recognises, and is recognised by all.

Industrialist Ratan Tata accompanied Prime Minister Narendra Modi for the inauguration of 7 cancer care centres in Assam.

Industrialist Ratan Tata accompanied Prime Minister Narendra Modi for the inauguration of 7 cancer care centres in Assam.&nbsp;At the event on April 28, the chairman of Tata Trusts revealed his mission in the last years of his life.&nbsp;Ratan Tata also addressed the gathering in Hindi, despite not being fluent in the language.
The cancer care centres are being set up by&nbsp;Assam Cancer Care Foundation (ACCF), a joint venture of the state government and Tata Trusts.
Tata said, "I can't make a speech in Hindi, so I shall try to communicate with all of you in English. The message will be the same. It will be from my heart. Today is a very important day in the history of the state of Assam. It is a day that raises Assam to a higher level in terms of healthcare and treatment of cancer that has not been experienced by the other states in the country."
Also watch:&nbsp;<a href="https://www.editorji.com/india-news/hospital-only-for-hindus-ratan-tata-asked-nitin-gadkari-at-rss-event-minister-reveals-reply-1649954357001" target="_blank">'Hospital only for Hindus?': Ratan Tata asked Nitin Gadkari at RSS event. Minister reveals reply</a>
Then Tata spoke in Hindi, "I shall not bore you with more statements. I shall just say that today is an important day for Assam. Today, Assam can tell the world that a small state has world-class cancer treatment centres. I thank the Prime Minister, Chief Minister, and PM Modi's government. I dedicate my last years to help make Assam a state that recognises, and is recognised by all."

World Cancer Day is celebrated internationally on 4th February to spread awareness of deadly cancer diseases. 


 World Cancer Day 2022: Know history, theme and significance of the day

World Cancer Day 2022: "Everyone deserves access to cancer care"

World Cancer Day is celebrated internationally on 4th February to spread awareness of deadly cancer diseases.

World Cancer Day is observed globally on 4 February to spread awareness about cancer and the stigma associated with the disease. The day was formed by the Union for International Cancer Control (UICC) in the year 1993.
Also watch:&nbsp;<a href="https://www.editorji.com/story/up-your-fruit-and-veggie-intake-to-lower-breast-cancer-risk-1632109442146">Up your fruit and veggie intake to lower breast cancer risk!</a>
World Cancer Day 2022 theme is 'Close the care gap- Everyone deserves access to cancer care'. It is a three-year campaign to identify and address the issue regarding the inequality in assessing cancer services worldwide.
According to the Cancer Statistics report, more than 13,92,179 cancer cases were reported in India in 2020. Breast, lung, cervical and thyroid are the most common cancers in women. On the other hand, cancer of the lung, prostate, stomach and liver are most common in men.
Also watch:&nbsp;<a href="https://www.editorji.com/lifestyle-news/health/juice-your-way-to-skin-cancer-prevention-fruity-concoction-shows-promise-in-study-1636606430067">Juice your way to skin cancer prevention? Fruity concoction shows promise in study</a>

Australia will be the first country to eliminate cervical cancer which could be as soon as within the next 20 years. This is according to a study conducted by researchers at the Cancer Council New South Wales, The country's screening programs and National vaccinations are the reason for this medical achievement. By 2022, the cancer maybe in the "rare" category in Australia and researchers are hopeful that the incidence of the disease will decrease if the screening for Human Papilloma virus (HPV) continues. Australia aims to set an example for the rest of the world.

cancer treatment

Categories